Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes

Frontiers in Aging Neuroscience

Thomas C. Foster¹  Michael R. Duggan²  Anne Lu²  Vinay Parikh²  Mathieu Wimmer² 

[1] Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL, United States;Department of Psychology and Neuroscience Program, Temple University, Philadelphia, PA, United States;

关键词: exosomes;    aging;    cognition;    biomarkers;    therapeutics;   

DOI  :  10.3389/fnagi.2022.834775

来源: DOAJ

【 摘 要 】

Aging is the most prominent risk factor for cognitive decline, yet behavioral symptomology and underlying neurobiology can vary between individuals. Certain individuals exhibit significant age-related cognitive impairments, while others maintain intact cognitive functioning with only minimal decline. Recent developments in genomic, proteomic, and functional imaging approaches have provided insights into the molecular and cellular substrates of cognitive decline in age-related neuropathologies. Despite the emergence of novel tools, accurately and reliably predicting longitudinal cognitive trajectories and improving functional outcomes for the elderly remains a major challenge. One promising approach has been the use of exosomes, a subgroup of extracellular vesicles that regulate intercellular communication and are easily accessible compared to other approaches. In the current review, we highlight recent findings which illustrate how the analysis of exosomes can improve our understanding of the underlying neurobiological mechanisms that contribute to cognitive variation in aging. Specifically, we focus on exosome-mediated regulation of miRNAs, neuroinflammation, and aggregate-prone proteins. In addition, we discuss how exosomes might be used to enhance individual patient outcomes by serving as reliable biomarkers of cognitive decline and as nanocarriers to deliver therapeutic agents to the brain in neurodegenerative conditions.

【 授权许可】

Unknown